Keywords: astrazeneca, sales, rise, 2nd, quarter, reported, increase
AstraZeneca sales rise 6.9% in 2nd quarter
Article | 05 August 2002
AstraZeneca has reported a 6.9% increase in sales for the second quarterof 2002, totaling $4.38 billion, as reported last week. Operating profit rose 22% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
